Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A block of the otic ganglion in chronic cluster headache
2016-004213-28Phase 2Completed
- Sponsor
- Department of Neuromedicine and Movement Science, NTNU
- Start
- Feb 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of botulinum toxin type A in Cluster Headache (CH), sponsored by Department of Neuromedicine and Movement Science, NTNU. Primary endpoint: Adverse events. Started Feb 2017; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on 2016-004213-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004213-28.